1999
DOI: 10.1016/s0167-5699(99)01547-9
|View full text |Cite
|
Sign up to set email alerts
|

T-cell priming by type-1and type-2 polarized dendritic cells: the concept of a third signal

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

27
679
0
11

Year Published

2000
2000
2012
2012

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 822 publications
(717 citation statements)
references
References 79 publications
27
679
0
11
Order By: Relevance
“…In our recent studies, we observed that strong IDO induction as a counterregulatory mechanism mediated APC activation [6,15], particularly when DCs were polarized by IFN-γ toward a DC1 phenotype [30,31]. Here, consistent with previous literature [25,26], we found that the cytokine and PGE 2 -matured DCs failed to produce the key cytokines characterizing a DC1 phenotype IL12p70 and IFN-γ [30,32] (Fig.…”
Section: Pge2 Stimulates DC Ido Competence But Not Proinflammatory Cysupporting
confidence: 91%
“…In our recent studies, we observed that strong IDO induction as a counterregulatory mechanism mediated APC activation [6,15], particularly when DCs were polarized by IFN-γ toward a DC1 phenotype [30,31]. Here, consistent with previous literature [25,26], we found that the cytokine and PGE 2 -matured DCs failed to produce the key cytokines characterizing a DC1 phenotype IL12p70 and IFN-γ [30,32] (Fig.…”
Section: Pge2 Stimulates DC Ido Competence But Not Proinflammatory Cysupporting
confidence: 91%
“…The capacity of DCs to direct the development of selected Th populations has been shown to be modulated by pathogens, cytokines, and other environmental factors 2. In particular, we have shown that DCs may induce the development of Th0 (or Th1 and Th2) lymphocytes in a neutral environment, and the differentiation of a polarized Th1 or Th2 population in the presence of IL-12 or IL-10, respectively 3.…”
Section: Introductionmentioning
confidence: 85%
“…DCs change their maturation status by upregulating surface expression of MHC class II and costimulatory molecules and by producing a defined set of cytokines to optimally induce distinct Th-cell responses [7][8][9]. Due to their immunostimulatory function, DCs are of particular interest in immunotherapy settings, such as cancer therapy and infectious disease intervention [10,11].…”
Section: Introductionmentioning
confidence: 99%